Most all of these small cap biotechs need or have to have a larger partner, if PANC doesn't partner up in the coming months I would stay away from the company as an investor. On the charts Fridays action is a trading bottom or a total breakdown of the somewhat positive trend in the stock. This weeks trading will tell the story, a retest of 52 lows or trending back up, with that said it's looking at if the early March spike was the exit point in PANC.
Market Data 
Markets 
AI
